|
|
Volumn 309, Issue 5735, 2005, Pages 731-734
|
|
Saving the mind faces high hurdles
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPETITION;
DISEASES;
DRUG PRODUCTS PLANTS;
ALZHEIMER'S DISEASE;
DRUG PRODUCTS;
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN;
BETA SECRETASE INHIBITOR;
CHOLINESTERASE INHIBITOR;
TACRINE;
MEDICINE;
ALZHEIMER DISEASE;
ARTICLE;
DEMENTIA;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG RESEARCH;
MEDICAL RESEARCH;
PRIORITY JOURNAL;
ALZHEIMER DISEASE;
ALZHEIMER VACCINES;
AMYLOID BETA-PROTEIN;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ASPARTIC ENDOPEPTIDASES;
BIOLOGICAL MARKERS;
BIOTECHNOLOGY;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
ENDOPEPTIDASES;
HUMANS;
MODELS, ANIMAL;
NERVE TISSUE PROTEINS;
NOOTROPIC AGENTS;
PHOSPHORYLATION;
PROTEASE INHIBITORS;
TAU PROTEINS;
|
|
EID: 23044474296
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.309.5735.731 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|